Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 1048 entries
View as:

Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)

Phase: N/A Priority: Normal
NCT ID: NCT00568464 Org: User:
Start: 03/31/07 End: 09/30/09 Due: 09/30/10

Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04758416 Org: User:
Start: 12/31/20 End: 12/31/22 Due: 12/31/23

Granisetron Transdermal Patch for Prophylaxis of Delayed CINV

Phase: N/A Priority: Normal
NCT ID: NCT04912271 Org: User:
Start: 06/10/21 End: 12/30/23 Due: 12/30/24

LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06387628 Org: User:
Start: 07/10/24 End: 04/01/27 Due: 04/01/28

Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)

Phase: N/A Priority: Normal
NCT ID: NCT04296162 Org: User:
Start: 03/10/20 End: 06/30/27 Due: 06/30/28

Diagnostic Accuracy of CCTA-derived Versus AngiogRaphy-dErived QuantitativE Flow Ratio (CAREER) Study

Phase: N/A Priority: Normal
NCT ID: NCT04665817 Org: User:
Start: 10/01/20 End: 12/31/22 Due: 12/31/23

Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation

Phase: N/A Priority: Normal
NCT ID: NCT04560426 Org: User:
Start: 10/31/20 End: 10/31/22 Due: 10/31/23

SHR-1701 Combined with SHR2554 and BP102 for MCRC

Phase: N/A Priority: Normal
NCT ID: NCT06679673 Org: User:
Start: 12/31/24 End: 12/31/26 Due: 12/31/27

Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

Phase: N/A Priority: Normal
NCT ID: NCT04524884 Org: User:
Start: 10/01/20 End: 09/30/22 Due: 09/30/23

A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04302441 Org: User:
Start: 11/10/16 End: 06/30/21 Due: 06/30/22

Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05435313 Org: User:
Start: 07/12/22 End: 02/29/24 Due: 02/28/25

Heating Precondition of Epidural Catheter Decrease the Incidence of Injury to Blood Vessel During Epidural Catheter Placement

Phase: N/A Priority: Normal
NCT ID: NCT02537665 Org: User:
Start: 06/30/15 End: - Due: -

Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinomaļ¼šFDZL-GC001 Trial

Phase: N/A Priority: Normal
NCT ID: NCT04510064 Org: User:
Start: 01/06/21 End: 07/31/24 Due: 07/31/25

A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

Phase: N/A Priority: Normal
NCT ID: NCT03475615 Org: User:
Start: 03/16/18 End: 12/31/20 Due: 12/31/21

Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06196671 Org: User:
Start: 12/01/24 End: 01/01/28 Due: 01/01/29

ZR-CHOP in DLBCL With Specific Gene Abnormality

Phase: N/A Priority: Normal
NCT ID: NCT05290337 Org: User:
Start: 01/04/22 End: 01/04/26 Due: 01/04/27

Next-generation Sequencing of Colorectal Cancer Somatic Cells to Guide Genetic Susceptibility Gene Mutations Screening.

Phase: N/A Priority: Normal
NCT ID: NCT04280666 Org: User:
Start: 06/20/19 End: 12/31/22 Due: 12/31/23

Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05063071 Org: User:
Start: 07/29/21 End: 12/29/22 Due: 12/29/23

Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02617082 Org: User:
Start: 10/31/15 End: - Due: -

Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03772353 Org: User:
Start: 05/12/19 End: 12/10/25 Due: 12/10/26

ALPPS Combined With Tislelizumab in Liver Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT04996446 Org: User:
Start: 08/01/20 End: 08/31/23 Due: 08/31/24

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06524167 Org: User:
Start: 07/02/24 End: 06/30/31 Due: 06/30/32

EMR Versus CSP in the Treatment of Sessile Serrated Lesions Less Than 10mm in Size

Phase: N/A Priority: Normal
NCT ID: NCT06609031 Org: User:
Start: 10/01/24 End: 10/01/26 Due: 10/01/27

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01403259 Org: User:
Start: 07/31/11 End: 12/31/15 Due: 12/31/16

A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.

Phase: N/A Priority: Normal
NCT ID: NCT05760391 Org: User:
Start: 02/28/23 End: 08/31/26 Due: 08/31/27